|5.||Pathologic Constriction (Stenosis)
|1.||Gershwin, M Eric: 21 articles (06/2014 - 06/2002)|
|2.||Nakanuma, Yasuni: 19 articles (05/2014 - 06/2002)|
|3.||Tsuneyama, Koichi: 16 articles (06/2014 - 06/2008)|
|4.||Takada, Tadahiro: 16 articles (01/2013 - 01/2006)|
|5.||Mayumi, Toshihiko: 15 articles (01/2013 - 01/2006)|
|6.||Tsuyuguchi, Toshio: 14 articles (08/2015 - 01/2007)|
|7.||Ansari, Aftab A: 14 articles (05/2014 - 06/2008)|
|8.||Yoshida, Masahiro: 14 articles (01/2013 - 01/2006)|
|9.||Lian, Zhe-Xiong: 13 articles (06/2014 - 06/2008)|
|10.||Zhang, Weici: 13 articles (06/2014 - 01/2009)|
|1.||Anti-Bacterial Agents (Antibiotics)IBA
08/01/1994 - "Although reestablishing biliary drainage is the mainstay of treatment, antibiotics play an important role in the management of cholangitis. "
11/01/1998 - "A 12-year-old girl who suffered from cholangitis was treated successfully with appropriate antibiotics. "
09/01/2010 - "All patients survived without any signs of recurrence (median 12 +/- 7 months); three patients, including two patients who underwent a palliative resection, had an attack of cholangitis, which was effectively treated with antibiotics. "
01/01/2016 - "Two cohort studies concluded that prophylactic antibiotics reduced incidence of cholangitis and one did not. "
01/01/2010 - "If one selects patients in whom the ERCP resolved the biliary obstruction at the first procedure, there seem to be no significant benefit in using prophylactic antibiotics to prevent cholangitis (RR 0.98, 95% CI 0.35 to 2.69, only three trials). "
|2.||Cefoperazone (Cefoperazone Sodium)FDA Link
12/01/2004 - "The efficacy of cefoperazone in the treatment of post-Kasai cholangitis has decreased over the last years. "
12/01/1980 - "[Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)]."
01/01/1981 - "In clinical studies in 116 patients with biliary tract infections such as cholecystitis, cholangitis, and liver abscess, cefoperazone was effective in 90 (78%). "
01/01/2011 - "She was diagnosed with acute suppurative cholangitis and treated with cefoperazone-sulbactam and an endoscopic drainage was performed. "
12/01/1980 - "A new antibiotic drug of cephalosporin, with marked resistance to beta-lactamase, cefoperazone (CPZ) for parenteral use was used in 10 patients with acute cholecystitis or cholangitis with cholelithiasis. "
|3.||Prednisolone (Predate)FDA LinkGeneric
01/01/1979 - "The cholangitis responded well to treatment with a low dose of prednisolone (7.5--10 mg) and an endoscopic retrograde cholangiopancreaticographic examination 10 months after the operation revealed normal bile ducts."
01/01/1985 - "Treatment with oral prednisolone appears to have precipitated an episode of ascending cholangitis in an asymptomatic 55-year-old patient. "
01/01/2014 - "After ensuring that the recurrent cholangitis was controlled by drainage and antibiotic therapy, oral prednisolone was initiated, and the patient's renal function and proteinuria subsequently gradually improved. "
11/07/2012 - "Newly developed autoimmune cholangitis without relapse of autoimmune pancreatitis after discontinuing prednisolone."
10/01/2014 - "A morphological and immunohistochemical study of the effects of prednisolone or ursodeoxycholic acid on liver histology in feline lymphocytic cholangitis."
|4.||Primary sclerosing cholangitisIBA
11/01/1993 - "Endoscopic therapy also has been effective in relieving symptoms, improving biochemical and radiologic abnormalities, and preventing recurrent cholangitis in patients with primary sclerosing cholangitis. "
10/01/2009 - "In this study, we conducted a morphological and immunohistochemical analysis of liver material obtained from individuals with IgG4-associated cholangitis, and compared these with well-characterized cases of primary sclerosing cholangitis. "
10/01/2009 - "IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material."
01/01/2015 - "Patients with primary sclerosing cholangitis (PSC) have an increased risk for adverse events following endoscopic retrograde cholangiopancreatography (ERCP), mainly caused by bacterial cholangitis. "
02/01/2014 - "4333 patients with cholangitis (including 178 with primary sclerosing cholangitis) were followed for 17 222 person-years. "
|5.||Ursodeoxycholic Acid (Urso)FDA LinkGeneric
06/01/2006 - "One of these three patients rarely exhibited acute cholangitis; administration of ursodeoxycholic acid resulted in complete remission. "
01/01/2003 - "Of 52 patients with autoimmune cholangitis treated with ursodeoxycholic acid in 13 uncontrolled studies, 83% had serum biochemical improvement. "
01/01/2015 - "Ursodeoxycholic acid (UDCA) is the standard treatment for primary biliary cholangitis (PBC), as it can delay histological progression, improve long-term outcome and is extremely safe and well tolerated. "
09/06/2006 - "Therapeutic interventions include mechanical endoscopic manipulation of the bile ducts, treatment of cholangitis and ursodeoxycholic acid. "
01/01/2000 - "Autoimmune cholangitis and AMA-positive PBC are quite similar in terms of clinical presentation, survival and response to ursodeoxycholic acid (UDCA) therapy. "
05/01/2015 - "This pilot study aimed to investigate whether Lactobacillus casei rhamnosus has the prophylactic efficacy for recurrent cholangitis in comparison with the conventional neomycin prophylaxis. "
05/01/2015 - "In the Lactobacillus group, 2 patients (20%, mean 0.03 ± 0.07 episodes per month) developed cholangitis during the study period, with the same frequency as in the neomycin group and significantly lower than that in the control group (80%, P = 0.005, mean 0.22 ± 0.16 episodes per month). "
05/01/2015 - "The use of L casei rhamnosus was as effective as neomycin in preventing cholangitis in patients with BA who underwent Kasai operation, and therefore could be considered as a potential alternative prophylactic regimen."
03/01/1994 - "Use of neomycin as the prophylaxis against recurrent cholangitis after Kasai portoenterostomy."
04/01/2003 - "Use of TMP/SMZ or neomycin is effective as a prophylactic agent against the recurrence of cholangitis after the Kasai portoenterostomy, but there is no difference in efficacy between these 2 regimens."
03/01/2002 - "Multivariate analysis revealed the model with the best ability to discriminate for CBD stones (P = 0.0005) was cholangitis, abnormal serum bilirubin for > or = 3 days and CBD diameter > or = 8 mm. The best predictors from this study had a sensitivity of 80% and a specificity of 27%. "
11/01/2014 - "The postoperative maximum serum total bilirubin levels (5.7 mg/dL vs 8.1 mg/dL, P = .035), morbidity rate (56% vs 78%, P = .001), and postoperative hospital stay (44 days vs 53 days, P = .021) were all greater in the cholangitis group compared with the noncholangitis group. "
07/01/2014 - "The optimal management of treatment for patients at intermediate risk of a common duct stone (including increased liver function tests but bilirubin <4 mg/dL and no cholangitis) is a matter of debate. "
01/01/2013 - "Total bilirubin (TB) levels (3, 6, and 12 months after surgery), early onset of cholangitis, and two-year native liver survival were evaluated. "
12/01/2012 - "These patients showed lower levels of bilirubin and higher levels of ALT than those with acute cholangitis with biliary dilatation, and had a shorter duration of hospital stay. "
12/01/2013 - "In patients with bile duct stones who were treated with biliary plastic stents, the best stent management to avoid cholangitis was stent changing at defined intervals (every 3 months in the current study). "
06/01/2012 - "The objective of this study was to compare the incidence of early stent occlusion (symptomatic occlusion/cholangitis necessitating re-insertion within 90 days) for wing stents and conventional plastic stents. "
03/01/2015 - "A 7-F double-pigtail plastic stent was therefore placed through the FCSEMS to correct the kink, straightening the common bile duct (CBD) and im-proving cholangitis. "
03/01/2014 - "Cholangitis resulting from a fragmented plastic biliary stent."
01/01/2014 - "Plastic stents were inserted to treat the acute cholangitis; however, the patient's symptoms recurred. "
09/01/2012 - "We describe the case of a 63-year old woman with a one-year history of episodes of cholangitis and a persistent elevation of alkaline phosphatase. "
01/01/2006 - "PSC was diagnosed on the basis of an elevated serum alkaline phosphatase and lymphocytic and fibrous cholangitis. "
05/01/2002 - "Patients with pathologic MRC findings had significantly higher levels of alkaline phosphatase (p < 0.05) and more frequently had histories of cholangitis than did patients with normal MRC. "
09/01/1994 - "Two of this group developed progressive cholangitis with raised serum alkaline phosphatase. "
05/01/1989 - "However, the mean value of serum alkaline phosphatase increased gradually after day 3, and was correlated with cholangitis. "
|10.||Penicillins (Penicillin)FDA Link
10/01/1990 - "We, therefore, conducted a three center, prospective, randomized trial to determine whether or not a broad spectrum penicillin alone is adequate therapy for patients with acute cholangitis. "
10/01/1990 - "These data suggest that outcome of treatment in patients with acute cholangitis is similar with either a broad spectrum penicillin or a penicillin plus aminoglycoside combination and is dependent upon the nature of the biliary obstruction."
10/01/1990 - "Broad spectrum penicillin as an adequate therapy for acute cholangitis."
03/01/1976 - "Escherichia coli and klebsiella were the organisms involved in more than 85 per cent of the positive cultures, and penicillin and an aminoglycoside are recommended as the drugs of choice in acute cholangitis. "
09/01/1985 - "The findings in this study lead to the following suggestions: vaccinate all children with pneumococcal vaccine at 2 years of age; a chest radiograph and dental evaluation should be obtained when evaluating the febrile child; empiric treatment for possible cholangitis should include an antipseudomonal penicillin derivative with an aminoglycoside; and if signs of peritonitis are present antibiotic treatment should also include antimicrobials effective against Haemophilus influenzae."
05/01/2012 - "The procedure was successful, and placement of a covered expandable metallic stent (C-EMS) relieved cholangitis. "
02/01/1999 - "For patients with major medical problems or who are at high surgical risk, however, endoscopic stent placement may help to prevent stone impaction and cholangitis. "
06/01/2009 - "Biliary drainage by 7 Fr stent or 10 Fr stent is equally safe and effective treatment for patients with severe cholangitis."
05/01/2005 - "Biliary drainage by nasobiliary drain and drainage by stent are equally safe and effective treatments for patients with severe cholangitis."
06/01/2009 - "We compared the safety and efficacy of 7 Fr and 10 Fr stent placement for biliary drainage in patients with acute cholangitis. "
11/01/1998 - "Endoscopic nasobiliary drainage without endoscopic sphincterotomy is a simple, safe, and effective treatment for acute cholangitis. "
08/01/1990 - "Endoscopic sphincterotomy resulted in an immediate clinical improvement in all patients, except in one patient who developed transient cholangitis; there was no mortality. "
02/01/2008 - "Three patients with bile-duct stones and acute cholangitis and with a previous biliary endoscopic sphincterotomy (ES) were included in this study. "
08/01/2002 - "This review is based on a presentation to a recent NIH "state of the science" conference on ERCP, and refers to an article which appears in this issue of Gut from researchers in Hong Kong who report on a randomised controlled trial of endoscopic sphincterotomy in acute cholangitis."
08/01/2002 - "A randomised controlled trial of endoscopic sphincterotomy in acute cholangitis without common bile duct stones."
06/01/2004 - "Urgent biliary decompression with endoscopic retrograde cholangiopancreatography in patients 90 years of age and older with severe acute cholangitis is a safe and effective procedure in the hands of highly skilled endoscopists and is not associated with increased morbidity or mortality even in this group of high risk patients."
01/01/2013 - "Endoscopic biliary decompression is an effective treatment for patients with acute obstructive cholangitis. "
04/01/1987 - "PTD is effective in providing decompression as initial therapy for acute cholangitis with minimal morbidity. "
09/01/1995 - "Retroperitoneal perforation was the only complication is a safe and effective procedure for emergency biliary decompression in the treatment of acute suppurative cholangitis."
07/01/2006 - "This study was undertaken to identify early predictors for emergency biliary decompression in patients with acute cholangitis. "
01/01/2003 - "We describe an unusual case of a laparoscopic common bile duct (CBD) injury that presented with cholangitis 2 years after an apparently uneventful laparoscopic cholecystectomy. "
07/01/2002 - "Right hepatic lobectomy for recurrent cholangitis after combined bile duct and right hepatic artery injury during laparoscopic cholecystectomy: a report of two cases."
10/26/2001 - "A 48-year-old patient was transferred to our hospital suffering from acute cholangitis due to complete bile duct occlusion one year after a laparoscopic cholecystectomy. "
01/01/2001 - "Laparoscopic cholecystectomy should be recommended after endoscopic management of cholangitis except in patients with prohibitive surgical risk.33333333333333333333333"
10/01/2000 - "She suffered from recurrent episodes of cholangitis due to injury of the major bile ducts during laparoscopic cholecystectomy. "
01/01/2011 - "Were examined the clinical, anamnestic data, clinical laboratory and instrumental studies of the condition of the hepatobiliary system in 127 patients with chronic cholangitis after cholecystectomy. "
07/01/2002 - "The purpose of this study was to analyze the role of elective cholecystectomy in preventing recurrent acute cholangitis in Asian patients. "
04/01/2015 - "During follow-up, the numbers of patients undergone cholecystectomy, cholangitis and recurrence of CBD stones were similar. "
07/01/2014 - "Unsuccessful ERCP (aOR, 1.7; 95% CI, 1.4-2.2), open cholecystectomy (aOR, 3.4; 95% CI 2.7-4.3), cholangitis (aOR, 1.9; 95% CI, 1.5-2.3), older age, having Medicare health insurance, and comorbidity were associated with increased mortality. "
01/01/2013 - "[Simultaneous surgical mithral-tricuspidal insufficiency correction and cholecystectomy with choledocholithotomy by acute cholangitis]."